Letter to the Editor
Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab
Taku Fujimura,
Corresponding Author
Taku Fujimura
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Correspondence: Taku Fujimura, M.D., Ph.D., Department of Dermatology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. Email:
[email protected]Search for more papers by this author Chinbing Lyu,
Chinbing Lyu
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Akira Tsukada,
Akira Tsukada
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Yota Sato,
Yota Sato
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Yumi Kambayashi,
Yumi Kambayashi
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Setsuya Aiba,
Setsuya Aiba
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author
Taku Fujimura,
Corresponding Author
Taku Fujimura
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Correspondence: Taku Fujimura, M.D., Ph.D., Department of Dermatology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. Email:
[email protected]Search for more papers by this author Chinbing Lyu,
Chinbing Lyu
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Akira Tsukada,
Akira Tsukada
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Yota Sato,
Yota Sato
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Yumi Kambayashi,
Yumi Kambayashi
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author Setsuya Aiba,
Setsuya Aiba
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for more papers by this author
First published: 24 October 2018
No abstract is available for this article.
References
- 1Freites-Martinez A, Kwong BY, Rieger KE et al. Eruptive keratoacanthomas associated with pembrolizumab therapy. JAMA Dermatol 2017; 153: 694–697.
- 2Kambayashi Y, Fujimura T, Aiba S. Comparison of immunosuppressive cells and immunomodulatory cells in kerartoacanthoma and invasive squamous cell carcinoma. Acta Derm Venereol 2013; 93: 663–668.
- 3Petretto A, Carbotti G, Inglese E et al. Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells. Oncotarget 2016; 7: 72518–72536.
- 4Sheng S, Zhang J, Ai J et al. Aberrant expression of IL-23/IL-23R in patients with breast cancer and its clinical significance. Mol Med Rep 2018; 17: 4639–4644.
- 5Wu L, Chen X, Zhao J et al. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J Exp Med 2015; 212: 1571–1587.
